Emmanuel Blot

3.0k total citations
50 papers, 1.4k citations indexed

About

Emmanuel Blot is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Emmanuel Blot has authored 50 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 9 papers in Cancer Research. Recurrent topics in Emmanuel Blot's work include Cancer Treatment and Pharmacology (9 papers), Breast Cancer Treatment Studies (9 papers) and Head and Neck Cancer Studies (8 papers). Emmanuel Blot is often cited by papers focused on Cancer Treatment and Pharmacology (9 papers), Breast Cancer Treatment Studies (9 papers) and Head and Neck Cancer Studies (8 papers). Emmanuel Blot collaborates with scholars based in France, Belgium and Monaco. Emmanuel Blot's co-authors include David Cameron, Jan Bogaerts, Martine Piccart, Étienne Brain, Thierry Petit, Hervé Bonnefoi, Richard Iggo, Gaëtan MacGrogan, Véronique Becette and Sylvie André and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Emmanuel Blot

50 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emmanuel Blot France 19 639 543 368 207 154 50 1.4k
Marc Oliva Spain 12 519 0.8× 472 0.9× 387 1.1× 271 1.3× 158 1.0× 41 1.2k
Brian M. Nolen United States 21 577 0.9× 547 1.0× 364 1.0× 138 0.7× 282 1.8× 28 1.6k
Salvatore Pisconti Italy 22 692 1.1× 502 0.9× 396 1.1× 434 2.1× 154 1.0× 97 1.7k
Chung-Tsen Hsueh United States 19 556 0.9× 416 0.8× 200 0.5× 305 1.5× 87 0.6× 55 1.2k
Hua‐Chien Chen Taiwan 25 556 0.9× 957 1.8× 688 1.9× 118 0.6× 130 0.8× 44 1.6k
Yoshiyasu Nakamura Japan 25 528 0.8× 650 1.2× 325 0.9× 398 1.9× 160 1.0× 71 1.6k
Li Yin China 27 505 0.8× 1.4k 2.6× 877 2.4× 181 0.9× 154 1.0× 99 2.0k
Karol Watson United States 7 524 0.8× 976 1.8× 584 1.6× 235 1.1× 101 0.7× 14 1.7k
Jochen Dahm‐Daphi Germany 26 776 1.2× 1.2k 2.3× 397 1.1× 356 1.7× 56 0.4× 45 1.7k
Robert W. Mutter United States 22 523 0.8× 374 0.7× 483 1.3× 418 2.0× 110 0.7× 84 1.6k

Countries citing papers authored by Emmanuel Blot

Since Specialization
Citations

This map shows the geographic impact of Emmanuel Blot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emmanuel Blot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emmanuel Blot more than expected).

Fields of papers citing papers by Emmanuel Blot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emmanuel Blot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emmanuel Blot. The network helps show where Emmanuel Blot may publish in the future.

Co-authorship network of co-authors of Emmanuel Blot

This figure shows the co-authorship network connecting the top 25 collaborators of Emmanuel Blot. A scholar is included among the top collaborators of Emmanuel Blot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emmanuel Blot. Emmanuel Blot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Trédan, Olivier, Philippe Follana, Isabelle Moullet, et al.. (2016). A phase III trial of exemestane plus bevacizumab maintenance therapy in patients with metastatic breast cancer after first-line taxane and bevacizumab: a GINECO group study. Annals of Oncology. 27(6). 1020–1029. 19 indexed citations
3.
Choussy, Olivier, et al.. (2011). Basaloid squamous cell carcinoma of the head and neck: report of 18 cases. The Journal of Laryngology & Otology. 125(6). 608–613. 6 indexed citations
4.
Mirshahi, Pezhman, Hong Li, Emmanuel Blot, et al.. (2011). Ovarian cancer: Stat3, RhoA and IGF-IR as therapeutic targets. Cancer Letters. 317(2). 207–217. 27 indexed citations
5.
Clatot, Florian, Jean‐Michel Picquenot, Olivier Choussy, et al.. (2011). Intratumoural level of SDF-1 correlates with survival in head and neck squamous cell carcinoma. Oral Oncology. 47(11). 1062–1068. 25 indexed citations
6.
Brain, Étienne, C. Mertens, Véronique Girre, et al.. (2010). Impact of liposomal doxorubicin-based adjuvant chemotherapy on autonomy in women over 70 with hormone-receptor-negative breast carcinoma: A French Geriatric Oncology Group (GERICO) phase II multicentre trial. Critical Reviews in Oncology/Hematology. 80(1). 160–170. 38 indexed citations
7.
Soria, Jeannette, Jérôme Alexandre, Marc Laurent, et al.. (2010). Stimulation of angiogenesis resulting from cooperation between macrophages and MDA-MB-231 breast cancer cells: proposed molecular mechanism and effect of tetrathiomolybdate. BMC Cancer. 10(1). 375–375. 33 indexed citations
8.
Clatot, Florian, et al.. (2009). Clinical improvement and survival in breast cancer leptomeningeal metastasis correlate with the cytologic response to intrathecal chemotherapy. Journal of Neuro-Oncology. 95(3). 421–426. 40 indexed citations
9.
Farmer, Pierre, Hervé Bonnefoi, Pascale Anderle, et al.. (2009). A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer. Nature Medicine. 15(1). 68–74. 483 indexed citations
10.
11.
Blot, Emmanuel, Linda L. Pritchard, Paule Opolon, et al.. (2006). Intravenous Delivery of Anti-RhoA Small Interfering RNA Loaded in Nanoparticles of Chitosan in Mice: Safety and Efficacy in Xenografted Aggressive Breast Cancer. Human Gene Therapy. 17(10). 1019–1026. 119 indexed citations
12.
Blot, Emmanuel, et al.. (2003). Outbreak of Clostridium difficile -related diarrhoea in an adult oncology unit: risk factors and microbiological characteristics. Journal of Hospital Infection. 53(3). 187–192. 60 indexed citations
13.
Blot, Emmanuel, Weihong Chen, Marc Vasse, et al.. (2003). Cooperation between monocytes and breast cancer cells promotes factors involved in cancer aggressiveness. British Journal of Cancer. 88(8). 1207–1212. 27 indexed citations
14.
Decaudin, Didier, Jozo Delić, J Dumont, et al.. (2002). Clinical Efficacy of Irradiation in CLL Patients: Predictive Value of in Vitro Radio-induced Apoptosis. Leukemia & lymphoma. 43(4). 827–829. 3 indexed citations
15.
Engelmann, C, Emmanuel Blot, Yves Panís, et al.. (2002). Apigenin – strong cytostatic and anti-angiogenic action in vitro contrasted by lack of efficacy in vivo. Phytomedicine. 9(6). 489–495. 28 indexed citations
16.
Blot, Emmanuel, et al.. (2002). Cancer-related thrombotic microangiopathy secondary to Von Willebrand factor-cleaving protease deficiency. Thrombosis Research. 106(2). 127–130. 22 indexed citations
17.
Bastit, Laurent, Emmanuel Blot, P. Debourdeau, et al.. (2001). Influence of the delay of adjuvant postoperative radiation therapy on relapse and survival in oropharyngeal and hypopharyngeal cancers. International Journal of Radiation Oncology*Biology*Physics. 49(1). 139–146. 46 indexed citations
18.
Blot, Emmanuel, Florence Cymbalista, C Engelmann, et al.. (2000). Apigenin inhibits endothelial-cell proliferation in G2/M phase whereas it stimulates smooth-muscle cells by inhibiting P21 and P27 expression. International Journal of Cancer. 85(5). 691–696. 43 indexed citations
19.
Blot, Emmanuel, H. Lévesque, Jean-François Ménard, et al.. (1999). Les dysthyroïdies auto-immunes liées au virus C existent-elles ? Réflexions à propos d'une étude contrôlée de 58 sujets consécutifs. La Revue de Médecine Interne. 20(3). 220–225. 2 indexed citations
20.
Cailleux, N., et al.. (1998). Histiocytose langerhansienne de l'adulte: localisations cutanéomuqueuses régressives après traitement par thalidomide. La Revue de Médecine Interne. 19(3). 196–198. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marc Oliva Breakdown of academic impact, for papers by Brian M. Nolen Breakdown of academic impact, for papers by Salvatore Pisconti Breakdown of academic impact, for papers by Chung-Tsen Hsueh Breakdown of academic impact, for papers by Hua‐Chien Chen Breakdown of academic impact, for papers by Yoshiyasu Nakamura Breakdown of academic impact, for papers by Li Yin Breakdown of academic impact, for papers by Karol Watson Breakdown of academic impact, for papers by Jochen Dahm‐Daphi Breakdown of academic impact, for papers by Robert W. Mutter
Rankless by CCL
2026